19-7184640-GGAGAGAGAGAGA-GGAGAGAGAGA
Variant names:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_000208.4(INSR):c.653-5_653-4delTC variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.13 in 1,315,650 control chromosomes in the GnomAD database, including 7,668 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.14 ( 1551 hom., cov: 0)
Exomes 𝑓: 0.13 ( 6117 hom. )
Consequence
INSR
NM_000208.4 splice_region, intron
NM_000208.4 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.176
Genes affected
INSR (HGNC:6091): (insulin receptor) This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 19-7184640-GGA-G is Benign according to our data. Variant chr19-7184640-GGA-G is described in ClinVar as [Benign]. Clinvar id is 196236.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-7184640-GGA-G is described in Lovd as [Benign]. Variant chr19-7184640-GGA-G is described in Lovd as [Likely_benign]. Variant chr19-7184640-GGA-G is described in Lovd as [Benign]. Variant chr19-7184640-GGA-G is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.188 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
INSR | NM_000208.4 | c.653-5_653-4delTC | splice_region_variant, intron_variant | Intron 2 of 21 | ENST00000302850.10 | NP_000199.2 | ||
INSR | NM_001079817.3 | c.653-5_653-4delTC | splice_region_variant, intron_variant | Intron 2 of 20 | NP_001073285.1 | |||
INSR | XM_011527988.3 | c.653-5_653-4delTC | splice_region_variant, intron_variant | Intron 2 of 21 | XP_011526290.2 | |||
INSR | XM_011527989.4 | c.653-5_653-4delTC | splice_region_variant, intron_variant | Intron 2 of 20 | XP_011526291.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
INSR | ENST00000302850.10 | c.653-5_653-4delTC | splice_region_variant, intron_variant | Intron 2 of 21 | 1 | NM_000208.4 | ENSP00000303830.4 | |||
INSR | ENST00000341500.9 | c.653-5_653-4delTC | splice_region_variant, intron_variant | Intron 2 of 20 | 1 | ENSP00000342838.4 | ||||
INSR | ENST00000598216.1 | n.628-5_628-4delTC | splice_region_variant, intron_variant | Intron 2 of 9 | 1 |
Frequencies
GnomAD3 genomes AF: 0.137 AC: 19520AN: 142016Hom.: 1550 Cov.: 0
GnomAD3 genomes
AF:
AC:
19520
AN:
142016
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.238 AC: 32849AN: 137742Hom.: 1340 AF XY: 0.243 AC XY: 18641AN XY: 76688
GnomAD3 exomes
AF:
AC:
32849
AN:
137742
Hom.:
AF XY:
AC XY:
18641
AN XY:
76688
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.129 AC: 151247AN: 1173544Hom.: 6117 AF XY: 0.133 AC XY: 77709AN XY: 584838
GnomAD4 exome
AF:
AC:
151247
AN:
1173544
Hom.:
AF XY:
AC XY:
77709
AN XY:
584838
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.137 AC: 19523AN: 142106Hom.: 1551 Cov.: 0 AF XY: 0.141 AC XY: 9736AN XY: 68910
GnomAD4 genome
AF:
AC:
19523
AN:
142106
Hom.:
Cov.:
0
AF XY:
AC XY:
9736
AN XY:
68910
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:5
Jul 10, 2015
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Jun 04, 2020
Genetic Services Laboratory, University of Chicago
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Oct 23, 2017
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
not provided Benign:4
Jun 09, 2021
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Dec 08, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
Leprechaunism syndrome;C0271695:Rabson-Mendenhall syndrome;C0342278:Insulin-resistant diabetes mellitus AND acanthosis nigricans;C1864952:Hyperinsulinism due to INSR deficiency Benign:1
Jan 24, 2022
Fulgent Genetics, Fulgent Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at